UFP Technologies, Inc. (UFPT)
USD 241.88
(-4.55%)
USD 241.88
(-4.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 118.04 Million USD | -15.68% |
| 2022 | 139.99 Million USD | 0.22% |
| 2021 | 139.68 Million USD | 430.9% |
| 2020 | 26.31 Million USD | -1.7% |
| 2019 | 26.76 Million USD | -45.53% |
| 2018 | 49.14 Million USD | 239.02% |
| 2017 | 14.49 Million USD | -2.59% |
| 2016 | 14.88 Million USD | -9.14% |
| 2015 | 16.37 Million USD | -12.41% |
| 2014 | 18.69 Million USD | -3.77% |
| 2013 | 19.43 Million USD | -23.37% |
| 2012 | 25.35 Million USD | 42.96% |
| 2011 | 17.73 Million USD | -17.82% |
| 2010 | 21.58 Million USD | 5.55% |
| 2009 | 20.44 Million USD | 21.48% |
| 2008 | 16.83 Million USD | -18.79% |
| 2007 | 20.72 Million USD | 4.7% |
| 2006 | 19.79 Million USD | -30.79% |
| 2005 | 28.6 Million USD | 12.57% |
| 2004 | 25.41 Million USD | 7.67% |
| 2003 | 23.6 Million USD | 10.64% |
| 2002 | 21.33 Million USD | -10.92% |
| 2001 | 23.94 Million USD | 4.92% |
| 2000 | 22.82 Million USD | 45.38% |
| 1999 | 15.7 Million USD | 12.14% |
| 1998 | 14 Million USD | 26.13% |
| 1997 | 11.1 Million USD | 8.82% |
| 1996 | 10.2 Million USD | 8.51% |
| 1995 | 9.4 Million USD | 9.3% |
| 1994 | 8.6 Million USD | 7.5% |
| 1993 | 8 Million USD | 6.67% |
| 1992 | 7.5 Million USD | 17.19% |
| 1991 | 6.4 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 112.22 Million USD | -0.39% |
| 2024 Q3 | 309.36 Million USD | 175.67% |
| 2024 Q1 | 112.66 Million USD | -4.56% |
| 2023 Q3 | 127.42 Million USD | -7.47% |
| 2023 Q2 | 137.7 Million USD | -4.57% |
| 2023 Q1 | 144.29 Million USD | 3.07% |
| 2023 FY | 118.04 Million USD | -15.68% |
| 2023 Q4 | 118.04 Million USD | -7.36% |
| 2022 FY | 139.99 Million USD | 0.22% |
| 2022 Q4 | 139.99 Million USD | -15.54% |
| 2022 Q3 | 165.75 Million USD | -11.72% |
| 2022 Q2 | 187.76 Million USD | 14.3% |
| 2022 Q1 | 164.26 Million USD | 17.6% |
| 2021 Q3 | 29.93 Million USD | -3.35% |
| 2021 Q4 | 139.68 Million USD | 366.66% |
| 2021 FY | 139.68 Million USD | 430.9% |
| 2021 Q2 | 30.97 Million USD | 9.21% |
| 2021 Q1 | 28.36 Million USD | 7.79% |
| 2020 Q3 | 28.22 Million USD | 0.78% |
| 2020 FY | 26.31 Million USD | -1.7% |
| 2020 Q4 | 26.31 Million USD | -6.78% |
| 2020 Q1 | 27.93 Million USD | 4.37% |
| 2020 Q2 | 28 Million USD | 0.25% |
| 2019 Q4 | 26.76 Million USD | -39.78% |
| 2019 Q3 | 44.44 Million USD | -1.9% |
| 2019 Q2 | 45.31 Million USD | -5.92% |
| 2019 Q1 | 48.16 Million USD | -1.99% |
| 2019 FY | 26.76 Million USD | -45.53% |
| 2018 Q3 | 57.96 Million USD | -6.9% |
| 2018 Q1 | 68.2 Million USD | 370.53% |
| 2018 Q2 | 62.25 Million USD | -8.72% |
| 2018 Q4 | 49.14 Million USD | -15.22% |
| 2018 FY | 49.14 Million USD | 239.02% |
| 2017 FY | 14.49 Million USD | -2.59% |
| 2017 Q1 | 16.11 Million USD | 8.29% |
| 2017 Q3 | 16.17 Million USD | 7.91% |
| 2017 Q2 | 14.99 Million USD | -6.96% |
| 2017 Q4 | 14.49 Million USD | -10.4% |
| 2016 Q2 | 16.46 Million USD | 15.95% |
| 2016 Q4 | 14.88 Million USD | -10.11% |
| 2016 Q3 | 16.55 Million USD | 0.52% |
| 2016 Q1 | 14.2 Million USD | -13.27% |
| 2016 FY | 14.88 Million USD | -9.14% |
| 2015 Q4 | 16.37 Million USD | -12.33% |
| 2015 Q2 | 18.33 Million USD | 8.25% |
| 2015 FY | 16.37 Million USD | -12.41% |
| 2015 Q3 | 18.68 Million USD | 1.88% |
| 2015 Q1 | 16.93 Million USD | -9.41% |
| 2014 Q1 | 17.83 Million USD | -8.23% |
| 2014 FY | 18.69 Million USD | -3.77% |
| 2014 Q4 | 18.69 Million USD | -2.28% |
| 2014 Q3 | 19.13 Million USD | 5.22% |
| 2014 Q2 | 18.18 Million USD | 1.99% |
| 2013 Q3 | 22.74 Million USD | -3.18% |
| 2013 Q2 | 23.49 Million USD | -2.06% |
| 2013 Q1 | 23.99 Million USD | -5.38% |
| 2013 Q4 | 19.43 Million USD | -14.59% |
| 2013 FY | 19.43 Million USD | -23.37% |
| 2012 Q3 | 18.15 Million USD | 4.13% |
| 2012 FY | 25.35 Million USD | 42.96% |
| 2012 Q1 | 17.2 Million USD | -3.0% |
| 2012 Q2 | 17.43 Million USD | 1.35% |
| 2012 Q4 | 25.35 Million USD | 39.66% |
| 2011 FY | 17.73 Million USD | -17.82% |
| 2011 Q1 | 21.11 Million USD | -2.15% |
| 2011 Q4 | 17.73 Million USD | -13.03% |
| 2011 Q3 | 20.39 Million USD | -2.42% |
| 2011 Q2 | 20.9 Million USD | -1.04% |
| 2010 Q1 | 19.55 Million USD | -4.34% |
| 2010 FY | 21.58 Million USD | 5.55% |
| 2010 Q3 | 20.46 Million USD | 3.07% |
| 2010 Q4 | 21.58 Million USD | 5.44% |
| 2010 Q2 | 19.85 Million USD | 1.54% |
| 2009 Q4 | 20.44 Million USD | -2.31% |
| 2009 Q2 | 17.44 Million USD | 3.12% |
| 2009 Q1 | 16.91 Million USD | 0.49% |
| 2009 FY | 20.44 Million USD | 21.48% |
| 2009 Q3 | 20.93 Million USD | 20.0% |
| 2008 Q1 | 21.21 Million USD | 2.37% |
| 2008 FY | 16.83 Million USD | -18.79% |
| 2008 Q4 | 16.83 Million USD | -15.87% |
| 2008 Q3 | 20 Million USD | -3.1% |
| 2008 Q2 | 20.64 Million USD | -2.69% |
| 2007 Q3 | 20.25 Million USD | 6.52% |
| 2007 Q4 | 20.72 Million USD | 2.33% |
| 2007 Q1 | 19.05 Million USD | -3.75% |
| 2007 FY | 20.72 Million USD | 4.7% |
| 2007 Q2 | 19.01 Million USD | -0.2% |
| 2006 Q1 | 25.99 Million USD | -9.12% |
| 2006 Q3 | 21.52 Million USD | -11.11% |
| 2006 Q4 | 19.79 Million USD | -8.02% |
| 2006 FY | 19.79 Million USD | -30.79% |
| 2006 Q2 | 24.21 Million USD | -6.85% |
| 2005 Q1 | 25.39 Million USD | -0.05% |
| 2005 Q4 | 28.6 Million USD | 5.03% |
| 2005 Q2 | 26.59 Million USD | 4.7% |
| 2005 FY | 28.6 Million USD | 12.57% |
| 2005 Q3 | 27.23 Million USD | 2.42% |
| 2004 Q2 | 24.16 Million USD | 1.35% |
| 2004 Q4 | 25.41 Million USD | 3.46% |
| 2004 FY | 25.41 Million USD | 7.67% |
| 2004 Q1 | 23.84 Million USD | 1.02% |
| 2004 Q3 | 24.56 Million USD | 1.64% |
| 2003 Q4 | 23.6 Million USD | 1.17% |
| 2003 FY | 23.6 Million USD | 10.64% |
| 2003 Q1 | 21.94 Million USD | 2.86% |
| 2003 Q3 | 23.32 Million USD | 2.6% |
| 2003 Q2 | 22.73 Million USD | 3.63% |
| 2002 Q3 | 22.09 Million USD | -10.34% |
| 2002 Q4 | 21.33 Million USD | -3.45% |
| 2002 Q2 | 24.64 Million USD | -4.35% |
| 2002 Q1 | 25.76 Million USD | 7.58% |
| 2002 FY | 21.33 Million USD | -10.92% |
| 2001 FY | 23.94 Million USD | 4.92% |
| 2001 Q1 | 24.05 Million USD | 5.38% |
| 2001 Q2 | 22.99 Million USD | -4.39% |
| 2001 Q3 | 23.59 Million USD | 2.58% |
| 2001 Q4 | 23.94 Million USD | 1.51% |
| 2000 FY | 22.82 Million USD | 45.38% |
| 2000 Q1 | 26.42 Million USD | 68.31% |
| 2000 Q2 | 26.42 Million USD | -0.0% |
| 2000 Q3 | 25.05 Million USD | -5.17% |
| 2000 Q4 | 22.82 Million USD | -8.91% |
| 1999 Q2 | 15.1 Million USD | 3.42% |
| 1999 Q4 | 15.7 Million USD | 3.97% |
| 1999 Q3 | 15.1 Million USD | 0.0% |
| 1999 FY | 15.7 Million USD | 12.14% |
| 1999 Q1 | 14.6 Million USD | 4.29% |
| 1998 Q1 | 11.1 Million USD | 0.0% |
| 1998 Q4 | 14 Million USD | 30.84% |
| 1998 FY | 14 Million USD | 26.13% |
| 1998 Q3 | 10.7 Million USD | -2.73% |
| 1998 Q2 | 11 Million USD | -0.9% |
| 1997 Q2 | 12 Million USD | -4.76% |
| 1997 Q1 | 12.6 Million USD | 23.53% |
| 1997 Q3 | 12 Million USD | 0.0% |
| 1997 Q4 | 11.1 Million USD | -7.5% |
| 1997 FY | 11.1 Million USD | 8.82% |
| 1996 Q3 | 10.4 Million USD | 4.0% |
| 1996 FY | 10.2 Million USD | 8.51% |
| 1996 Q4 | 10.2 Million USD | -1.92% |
| 1996 Q2 | 10 Million USD | -0.99% |
| 1996 Q1 | 10.1 Million USD | 7.45% |
| 1995 FY | 9.4 Million USD | 9.3% |
| 1995 Q1 | 8.9 Million USD | 3.49% |
| 1995 Q3 | 9.1 Million USD | 8.33% |
| 1995 Q2 | 8.4 Million USD | -5.62% |
| 1995 Q4 | 9.4 Million USD | 3.3% |
| 1994 Q1 | 7.2 Million USD | -10.0% |
| 1994 FY | 8.6 Million USD | 7.5% |
| 1994 Q3 | 8 Million USD | -1.23% |
| 1994 Q4 | 8.6 Million USD | 7.5% |
| 1994 Q2 | 8.1 Million USD | 12.5% |
| 1993 Q4 | 8 Million USD | 0.0% |
| 1993 FY | 8 Million USD | 6.67% |
| 1992 Q4 | 7.5 Million USD | 0.0% |
| 1992 FY | 7.5 Million USD | 17.19% |
| 1991 Q4 | 6.4 Million USD | 0.0% |
| 1991 FY | 6.4 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | -115.257% |
| Axonics, Inc. | 82.35 Million USD | -43.33% |
| INVO Bioscience, Inc. | 19.99 Million USD | -490.374% |
| CVRx, Inc. | 39.28 Million USD | -200.507% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 47.076% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -3609.84% |
| MaxCyte, Inc. | 36.1 Million USD | -226.931% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -449.353% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 4.776% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1690.46% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -130.314% |
| Apyx Medical Corporation | 52.31 Million USD | -125.63% |
| Cutera, Inc. | 518.12 Million USD | 77.217% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -2109.753% |
| NeuroPace, Inc. | 86.99 Million USD | -35.689% |
| IRIDEX Corporation | 24.91 Million USD | -373.81% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -34.454% |
| enVVeno Medical Corporation | 2.43 Million USD | -4747.844% |
| TELA Bio, Inc. | 59.16 Million USD | -99.512% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 81.527% |
| Modular Medical, Inc. | 2.27 Million USD | -5095.643% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -302.499% |
| LENSAR, Inc. | 22.4 Million USD | -426.775% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 94.62% |
| Surmodics, Inc. | 65.82 Million USD | -79.337% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -1043.958% |
| Inogen, Inc. | 121.38 Million USD | 2.749% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -6951.673% |
| RxSight, Inc. | 22.18 Million USD | -432.022% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -27656.942% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -299.057% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -410.266% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -27656.942% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -4759.219% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -12.848% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 83.22% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -363.594% |
| Dynatronics Corporation | 11.78 Million USD | -902.07% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -128.49% |
| InMode Ltd. | 75.91 Million USD | -55.498% |
| Bruker Corporation | 2.83 Billion USD | 95.839% |
| Movano Inc. | 5.97 Million USD | -1876.641% |
| Orthofix Medical Inc. | 326.58 Million USD | 63.855% |
| FONAR Corporation | 57.45 Million USD | -105.447% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2419.637% |
| Envoy Medical, Inc. | 9.4 Million USD | -1155.531% |
| Align Technology, Inc. | 2.45 Billion USD | 95.188% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -102.246% |
| Talis Biomedical Corporation | 29.22 Million USD | -303.932% |
| Cerus Corporation | 144.3 Million USD | 18.197% |
| 908 Devices Inc. | 37.49 Million USD | -214.871% |
| Nemaura Medical Inc. | 26.37 Million USD | -347.523% |
| Outset Medical, Inc. | 190.91 Million USD | 38.169% |
| NanoVibronix, Inc. | 2.68 Million USD | -4294.825% |
| Venus Concept Inc. | 107.1 Million USD | -10.216% |
| Telesis Bio, Inc. | 40.87 Million USD | -188.809% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -3.576% |
| Quipt Home Medical Corp. | 136.29 Million USD | 13.389% |
| IRadimed Corporation | 20.73 Million USD | -469.277% |
| Tenon Medical, Inc. | 5.56 Million USD | -2020.442% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3204.731% |
| Pulmonx Corporation | 60.63 Million USD | -94.678% |
| iCAD, Inc. | 8 Million USD | -1375.378% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -830.184% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -6288.028% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -189.395% |
| SI-BONE, Inc. | 61.05 Million USD | -93.358% |
| Semler Scientific, Inc. | 6.27 Million USD | -1782.695% |
| Biotricity, Inc. | 35.91 Million USD | -228.638% |
| Cytosorbents Corporation | 29.98 Million USD | -293.674% |
| DexCom, Inc. | 4.19 Billion USD | 97.187% |
| ZimVie Inc. | 795.85 Million USD | 85.167% |
| Aethlon Medical, Inc. | 2.47 Million USD | -4660.551% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -887.157% |
| IceCure Medical Ltd | 4.24 Million USD | -2679.491% |
| PAVmed Inc | 57.13 Million USD | -106.6% |
| Sight Sciences, Inc. | 46.43 Million USD | -154.21% |
| Insulet Corporation | 1.85 Billion USD | 93.638% |
| Profound Medical Corp. | 12.66 Million USD | -831.993% |
| electroCore, Inc. | 8.94 Million USD | -1219.676% |
| Bioventus Inc. | 589.79 Million USD | 79.985% |
| InspireMD, Inc. | 8.14 Million USD | -1349.828% |
| PAVmed Inc. | 57.13 Million USD | -106.6% |
| Nuwellis, Inc. | 6.78 Million USD | -1641.077% |
| OrthoPediatrics Corp. | 72.56 Million USD | -62.684% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -887.157% |
| BrainsWay Ltd. | 15.31 Million USD | -670.831% |
| BIOLASE, Inc. | 35.34 Million USD | -233.951% |
| Beyond Air, Inc. | 29.77 Million USD | -296.457% |
| AxoGen, Inc. | 101.16 Million USD | -16.689% |
| Inari Medical, Inc. | 209.32 Million USD | 43.607% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -5300.51% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -6535.469% |
| AdaptHealth Corp. | 3.15 Billion USD | 96.256% |
| Quanterix Corporation | 78.08 Million USD | -51.177% |
| Viveve Medical, Inc. | 10.84 Million USD | -988.273% |
| LivaNova PLC | 1.15 Billion USD | 89.752% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -569.413% |
| Varex Imaging Corporation | 668.6 Million USD | 82.344% |
| Vivani Medical, Inc. | 25.03 Million USD | -371.501% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -2804.651% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3204.731% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -2316.479% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 88.701% |
| TransMedics Group, Inc. | 568.84 Million USD | 79.248% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -607.619% |
| NeuroMetrix, Inc. | 1.33 Million USD | -8754.765% |
| Spectral AI, Inc. | 12.4 Million USD | -851.899% |
| Hyperfine, Inc. | 9.8 Million USD | -1104.541% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 52.828% |
| Biomerica, Inc. | 2.66 Million USD | -4332.783% |
| Bone Biologics Corporation | 831.4 Thousand USD | -14098.306% |
| AVITA Medical, Inc. | 19.86 Million USD | -494.224% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -5880.95% |
| Silk Road Medical, Inc | 114.15 Million USD | -3.405% |